Incuron Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 6

Incuron General Information


Developer of innovative drugs designed to treat cancer. The company's drugs offer pre-clinical and clinical development of breakthrough bio-technologies, enabling to clients to get proper and required drugs for cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 73 High Street
  • Buffalo, NY 14203
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Incuron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 29-Apr-2015 $4M 0000 000 Completed Generating Revenue
3. Grant 19-Sep-2011 000 0000 Completed Startup
2. Early Stage VC 26-Apr-2010 $18M $18M Completed Startup
1. Joint Venture 01-Jan-2010 Completed Startup
To view Incuron’s complete valuation and funding history, request access »

Incuron Executive Team (7)

Name Title Board Seat Contact Info
Kristina Zakurdaeva Ph.D Chief Executive Officer
Roman Ivanov Ph.D Deputy Director
Andrei Purmal Ph.D Chief Operating Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Incuron Board Members (6)

Name Representing Role Since
Andrei Gudkov Ph.D Cleveland Biolabs Board Member 000 0000
Mikhail Mogutov Ph.D Bioprocess Capital Partners Chairman 000 0000
Vladimir Tezov MD Bioprocess Capital Partners Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Incuron Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mikhail Mogutov Angel (individual) Minority 000 0000 000000 0
Skolkovo Foundation Limited Partner 000 0000 000000 0
Russian Venture Company Venture Capital Minority 000 0000 000000 0
Vnesheconombank Limited Partner Minority 000 0000 000000 0
Bioprocess Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »